Skip to main content
OpenTrials

Clinical trial condition

Metastatic Renal Cell Carcinoma

Explore clinical trials studying Metastatic Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

125 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Renal Cell Carcinoma trial results

Completed

Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)

NCT01266837

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Charitè Campus Benjamin Franklin Berlin, Germany
  • Klinik und Poliklinik für Urologie , Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Dresden, Germany
  • Urologie - Waldkrankenhaus St. Marien Erlangen, Germany
  • Klinik für Innere Medizin (Tumorforschung), Universitätsklinikum Essen Essen, Germany
View Trial Details
Completed

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

NCT01265901

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Cedars-Siani Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Kaiser Permanente Oncology Hematology Clinic Denver, Colorado, United States
  • Georgetown University Medical Center, Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 105 locations
View Trial Details
Completed

Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00357760

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States
  • Porter Adventist Hospital Denver, Colorado, United States
View all 205 locations
View Trial Details
Completed

Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma

NCT01491672

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Novartis Investigative Site San Miguel de Tucumán, Tucumán Province, Argentina
  • Novartis Investigative Site Rio Negro, Viedma, Argentina
  • Novartis Investigative Site Florianópolis, Santa Catarina, Brazil
View all 17 locations
View Trial Details
Completed

Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

NCT01223027

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) La Jolla, California, United States
  • Cedars Sinai Medical Center Cedars Sinai Medical Ctr. (SC) Los Angeles, California, United States
  • University of California at Los Angeles UCLA (4) Los Angeles, California, United States
View all 199 locations
View Trial Details

Related conditions